|
|
|
|
![]() |
| Reinventing Therapeutics Through Chemical Genomics | |
|
|
|
| top > Company > Investors | |
Investors |
|
The company has raised a total of $9M in three rounds of funding in April, 2002, April, 2003 and July, 2004. Aphoenix's Investors are as follows: |
|
|
- Nomura Research & Advisory |
| - JAFCO | |
| - SBI TransScience | |
| - Bio-sight Capital |
